Boston Scientific
$30.989876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$30.98
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.81 (-2.58%) Today
+$0.37 (+1.21%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell BSX and other stocks, options, ETFs, and crypto commission-free!
About BSX
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. Read More The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
Employees
36,000
Headquarters
Marlborough, Massachusetts
Founded
1979
Market Cap
41.77B
Price-Earnings Ratio
9.43
Dividend Yield
—
Average Volume
15.46M
High Today
$31.39
Low Today
$29.47
Open Price
$30.25
Volume
11.23M
52 Week High
$46.62
52 Week Low
$24.10
Collections
BSX News
Analyst Ratings
87%
of 23 ratings
Buy
87%
Hold
9%
Sell
4%
BSX Earnings
$0.00
$0.15
$0.31
$0.46
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected Apr 22, Pre-Market